MOH — authorised 24 July 1967
- Marketing authorisation holder: PFIZER
- Status: likely_approved
MOH authorised Navane on 24 July 1967
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 24 July 1967.
PFIZER holds the Israeli marketing authorisation.